Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R King

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trialChristopher R King, James D Brooks, Harcharan Gill, et al.
Journal of Biomedical Informatics|February 12, 2024
Multi-view representation learning for tabular data integration using inter-feature relationshipsSandhya Tripathi, Bradley A Fritz, Mohamed Abdelhack, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 2013
Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trialsChristopher R King, Sean Collins, Donald Fuller, et al.
Urology|June 13, 2006
Reliability of small amounts of cancer in prostate biopsies to reveal pathologic gradeChristopher R King, John E McNeal, Harcharan Gill, et al.
American Journal of Clinical Oncology|August 4, 2015
Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical ProstatectomyJung J Kang, Robert E Reiter, Nicolas Kummer, et al.
The Journal of Urology|March 23, 2011
Does hormone therapy exacerbate the adverse effects of radiotherapy in men with prostate cancer? A quality of life studyJonathan D Grant, Mark S Litwin, Lorna Kwan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomyDeep A Patel, Joseph C Presti, John E McNeal, et al.
Practical Radiation Oncology|March 10, 2015
Dosimetric parameters predict short-term quality-of-life outcomes for patients receiving stereotactic body radiation therapy for prostate cancerCaitlin L Gomez, Xiaoqing Xu, X Sharon Qi, et al.
JAMA Network Open|March 30, 2021
Use of Machine Learning to Develop and Evaluate Models Using Preoperative and Intraoperative Data to Identify Risks of Postoperative ComplicationsBing Xue, Dingwen Li, Chenyang Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapyAmar U Kishan, James M Lamb, Shyam S Jani, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trialChristopher R King, James D Brooks, Harcharan Gill, et al.
Journal of Biomedical Informatics|February 12, 2024
Multi-view representation learning for tabular data integration using inter-feature relationshipsSandhya Tripathi, Bradley A Fritz, Mohamed Abdelhack, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 2013
Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trialsChristopher R King, Sean Collins, Donald Fuller, et al.
Urology|June 13, 2006
Reliability of small amounts of cancer in prostate biopsies to reveal pathologic gradeChristopher R King, John E McNeal, Harcharan Gill, et al.
American Journal of Clinical Oncology|August 4, 2015
Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical ProstatectomyJung J Kang, Robert E Reiter, Nicolas Kummer, et al.
The Journal of Urology|March 23, 2011
Does hormone therapy exacerbate the adverse effects of radiotherapy in men with prostate cancer? A quality of life studyJonathan D Grant, Mark S Litwin, Lorna Kwan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomyDeep A Patel, Joseph C Presti, John E McNeal, et al.
Practical Radiation Oncology|March 10, 2015
Dosimetric parameters predict short-term quality-of-life outcomes for patients receiving stereotactic body radiation therapy for prostate cancerCaitlin L Gomez, Xiaoqing Xu, X Sharon Qi, et al.
JAMA Network Open|March 30, 2021
Use of Machine Learning to Develop and Evaluate Models Using Preoperative and Intraoperative Data to Identify Risks of Postoperative ComplicationsBing Xue, Dingwen Li, Chenyang Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapyAmar U Kishan, James M Lamb, Shyam S Jani, et al.
Pageof 12